FormularyDecisions

0

Differentiate Your Product From the Competition: Give Healthcare Decision Makers the Information They Need

Posted on by tHEORetically Speaking

In this competitive pharmaceutical market access landscape, payers are preparing budgets and financial forecasts well ahead of product launches, meaning they require product information earlier and earlier in the pre-approval stage. Patti Peeples, PhD of HealthEconomics.com sits down with Xcenda’s… Continue Reading →

0

Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement

Posted on by Patti Peeples, R.Ph., Ph.D.

The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading →

0

Payer Contact in a “Contactless” World: Achieving Early Engagement

Posted on by Patti Peeples, R.Ph., Ph.D.

In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading →